Eye Care News

Researchers advance the field of retinoblastoma research through the discovery and use of aqueous humor biopsy. Genetic tumor information not present in the blood can be detected in this fluid from the eye.

Zebrafish research is a promising way to understand the neural and genetic causes of eye movement problems in people, according to multi-university research.

Study authors note multiple health issues including blurred vision from excessive screen time, neck and back pain from poor posture, carpal tunnel syndrome from repetitive motion, metabolic dysregulation from prolonged sitting and high consumption of caffeine and sugar, and depression and anxiety resulting from internet gaming disorder.

Defying the odds, an individual at high risk for early-onset Alzheimer’s disease remained dementia-free for many years beyond what was anticipated. A new study led researchers to suggest that a gene variant may be the key, perhaps providing a new direction toward developing a treatment.

A genetic mutation that leads to a rare, but devastating blindness-causing condition called Bardet-Biedl Syndrome has been discovered in monkeys for the first time. The finding offers a promising way to develop gene and cell therapies that could treat people with the condition, which leads to vision loss, kidney disfunction, extra fingers or toes, and other symptoms.

Sequencing and timing of cataract surgery do not affect trabeculectomy success rates at 5 years, according this retrospective study.

This secondary analysis of the Protocol S trial compared the cost-effectiveness of ranibizumab versus laser for proliferative diabetic retinopathy.

The authors of this study investigated donor and recipient factors associated with operative complications in patients undergoing Descemet stripping automated endothelial keratoplasty (DSAEK).

This week, a Netflix documentary details a family’s quest to obtain the pricey gene therapy Luxturna for their child, Aldeyra’s experimental allergic conjunctivitis drug continues to impress and a young engineer may have solved a blind spot problem in cars.

This paper reports the first case of melanoma-associated retinopathy (MAR) to be managed using intravitreal fluocinolone acetonide implants.